Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-05T04:16:34.126Z Has data issue: false hasContentIssue false

Late-life sleep duration associated with amnestic mild cognitive impairment

Published online by Cambridge University Press:  10 May 2021

Mengya Yuan
Affiliation:
Department of Geriatric Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine and Alzheimer’s Disease and Related Disorders Center, Shanghai Jiao Tong University, Shanghai, China
Bo Hong
Affiliation:
Department of Geriatric Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine and Alzheimer’s Disease and Related Disorders Center, Shanghai Jiao Tong University, Shanghai, China
Wei Zhang
Affiliation:
Department of Geriatric Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine and Alzheimer’s Disease and Related Disorders Center, Shanghai Jiao Tong University, Shanghai, China
An Liu
Affiliation:
Department of Geriatric Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine and Alzheimer’s Disease and Related Disorders Center, Shanghai Jiao Tong University, Shanghai, China
Jinghua Wang
Affiliation:
Department of Geriatric Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine and Alzheimer’s Disease and Related Disorders Center, Shanghai Jiao Tong University, Shanghai, China
Yuanyuan Liu
Affiliation:
Department of Geriatric Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine and Alzheimer’s Disease and Related Disorders Center, Shanghai Jiao Tong University, Shanghai, China
Feng Yan
Affiliation:
Department of Geriatric Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine and Alzheimer’s Disease and Related Disorders Center, Shanghai Jiao Tong University, Shanghai, China
Shifu Xiao
Affiliation:
Department of Geriatric Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine and Alzheimer’s Disease and Related Disorders Center, Shanghai Jiao Tong University, Shanghai, China
Hua Xu*
Affiliation:
Department of Geriatric Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine and Alzheimer’s Disease and Related Disorders Center, Shanghai Jiao Tong University, Shanghai, China
Tao Wang*
Affiliation:
Department of Geriatric Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine and Alzheimer’s Disease and Related Disorders Center, Shanghai Jiao Tong University, Shanghai, China
*
Correspondence should be addressed to: Tao Wang; Hua Xu, Department of Geriatric Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, 600 South Wan Ping Road, Xu Hui District, Shanghai, China. Phone: +86 21 64387250; Fax: +86 21 54259931. Email: [email protected]; [email protected].
Correspondence should be addressed to: Tao Wang; Hua Xu, Department of Geriatric Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, 600 South Wan Ping Road, Xu Hui District, Shanghai, China. Phone: +86 21 64387250; Fax: +86 21 54259931. Email: [email protected]; [email protected].
Rights & Permissions [Opens in a new window]

Abstract

Objective:

To examine the association between sleep duration in different stages of life and amnestic mild cognitive impairment (aMCI).

Design, setting, and participants:

A total of 2472 healthy elderly and 505 patients with aMCI in China were included in this study. The study analyzed the association between aMCI and sleep duration in different stages of life.

Measurements:

We compared sleep duration in different stages of life and analyzed the association between Montreal Cognitive Assessment scores and sleep duration by curve estimation. Logistic regression was used to evaluate the association between aMCI and sleep duration.

Results:

In the analysis, there were no results proving that sleep duration in youth (P = 0.719, sleep duration < 10 hours; P = 0.999, sleep duration ≥ 10 hours) or midlife (P = 0.898, sleep duration < 9 hours; P = 0.504, sleep duration ≥ 9 hours) had a significant association with aMCI. In the group sleeping less than 7 hours in late life, each hour more of sleep duration was associated with approximately 0.80 of the original risk of aMCI (P = 0.011, odds ratio = 0.80, 95% confidence interval = 0.68–0.95).

Conclusions:

Among the elderly sleeping less than 7 hours, there is a decreased risk of aMCI for every additional hour of sleep.

Type
Original Research Article
Copyright
© International Psychogeriatric Association 2021

Introduction

Mild cognitive impairment (MCI) generally refers to cognitive impairment that is more severe than that observed with normal aging, but not severe enough to cause apparently impaired daily function (Crous-Bou et al., Reference Crous-Bou, Minguillón, Gramunt and Molinuevo2017; Sanford, Reference Sanford2017). It is conceptualized as a boundary or a transitional state between aging and dementia (Morris et al., Reference Morris2001). Amnestic MCI (aMCI) is the most common phenotype of MCI, which has impairment in tests of episodic memory. It is associated with a considerable risk of further development to Alzheimer’s disease (AD; Campbell et al., Reference Campbell, Unverzagt, Lamantia, Khan and Boustani2013; Chung et al., Reference Chung2019; Kasper et al., Reference Kasper2020). Patients with aMCI have a conversion rate of 60.5∼100% to AD in 5∼10 years (Liu et al., Reference Liu2020), imposing a heavy psychological and financial burden on affected individuals, caregivers, and society. Currently, in view of no effective cure for aMCI and AD (Anderson et al., Reference Anderson, Hadjichrysanthou, Evans and Wong2017), it is crucial to study relevant risk and protective factors to protect elderly people against aMCI and AD.

Growing evidence has shown a bidirectional relationship between sleep problems and MCI (Chen et al., Reference Chen2016; Guarnieri and Sorbi, Reference Guarnieri and Sorbi2015) or AD (Ohayon and Vecchierini, Reference Ohayon and Vecchierini2002; Shi et al., Reference Shi2018; Wams et al., Reference Wams, Wilcock, Foster and Wulff2017). More than 60% of MCI and AD patients have at least one sleep disorder (Guarnieri et al., Reference Guarnieri2012). Patients with sleep problems have an increased risk of AD. Sleep duration is one of the most important sleep characteristics. However, the association between sleep duration and cognitive function is still inconclusive. Several studies have shown that prolonged sleep duration is significantly associated with poor cognitive function (Schmutte et al., Reference Schmutte, Harris, Levin, Zweig, Katz and Lipton2007). Conversely, a lack of sleep was associated with cognitive decline (Tworoger et al., Reference Tworoger, Lee, Schernhammer and Grodstein2006). Moreover, other studies have shown that either too short or too long sleep duration affected cognitive function(Benito-León et al., Reference Benito-León, Louis and Bermejo-Pareja2013; Chen et al., Reference Chen2016; Ding et al., Reference Ding, Li and Lian2020; Xu et al., Reference Xu, Tan, Zou, Cao and Tan2020a). In addition, most studies have mainly focused on recent sleep duration being experienced in late life. Few studies have focused on sleep duration in youth or in midlife.

In this study, we conducted a cross-sectional study with elderly individuals who were systematically recruited in city communities to examine the association between sleep duration in different stages of life and aMCI.

Materials and methods

Subjects

The China Longitudinal Aging Study (Xiao et al., Reference Xiao2013) is a long-duration population-based cohort study that focuses on the elderly population living in city communities in China. Participants were recruited from 15 sites of 8 provinces including Shanghai, Beijing, Guangdong, Zhejiang, Jiangxi, Liaoning, Shanxi, and Anhui in China. A total of 3,510 participants completed the interview during 2011 and 2012. A total of 2,977 participants were included in this study after excluding participants without complete demographic information (n = 11), aged less than 60 years old (n = 14), without diagnosis (n = 44), diagnosed with dementia (n = 173), diagnosed with vascular MCI (VMCI, n = 93), diagnosed with depression disorder (n = 20), diagnosed with other diseases, as generalized anxiety disorder, panic disorder, sub-clinical depression (n = 166), without sleep information (n = 12). Of the 2,977 participants, 505 participants were diagnosed with aMCI and defined as the aMCI group; 2,472 participants were normal aging elderly included in the healthy comparison (HC) group.

Ethical approval was obtained from Shanghai Mental Health Centre (IRB approval number: 2012-19; date: 2012-04-12). All participants signed an informed consent form before the study was initiated.

Data collection and diagnostic criteria

Each research center utilized the same questionnaire structured by the Shanghai Brain Health Foundation. The questionnaire consisted of five sections: sociodemographic characteristics and lifestyle, medical history, sleep patterns, weight and height, and emotional and psychosocial tests. In the “sociodemographic characteristics and lifestyle” section, we collected name, gender, age, educational years, smoking history, alcohol consumption, tea consumption, and physical activity. In the “medical history” section, we mainly collected histories of hypertension, heart disease, and diabetes. Sleep patterns were reported by the participants themselves, including nighttime sleep duration in their youth (18–44 years old), midlife (45–59 years old), and late life (over 60 years old). The subjects were asked “How many hours do you sleep on average in their youth (18 to 44 years old), midlife (45 to 59 years old), and late life (over 60 years old)?” We also asked the elderly about the time when they get up and fall in sleep to check the response. Furthermore, the response was verified by their families. Based on the weight and height, we calculated body mass index (BMI) = weight/height2 (kg/m2). Emotional and psychosocial tests included the Mini-Mental State Examination (O’Bryant et al., Reference O’Bryant2008) and the Montreal Cognitive Assessment (MoCA) (Gil et al., Reference Gil, Vega, Ruiz de Sanchez and Burgos2013). The Hachinski Ischemic Scale (Moroney et al., Reference Moroney, Bagiella, Desmond, Hachinski and Tatemichi1997) was used to exclude vascular dementia and VMCI. The Geriatric Depression Scale (Lin et al., Reference Lin2016) was used to exclude depression disorder.

The diagnostic criteria for aMCI, which were adapted from the MCI diagnostic criteria of Petersen (Portet et al., Reference Portet2006), were as follows: (1) memory complaints, preferably corroborated by an informant; (2) objective memory impairment; (3) preservation of general cognitive function; (4) intact activities of daily living; and (5) absence of dementia.

The diagnostic criteria for normal aging were as follows: (1) normal recognition, (2) no other severe physical disease, and (3) ability to cooperate and complete the relevant tests.

Statistical analyses

Statistical analyses were performed with SPSS version 22.0. Descriptive statistics were used in the analysis of sociodemographic characteristics, lifestyle, medical history, psychosocial tests, and sleep duration assessments. All continuous variables were tested for normality with the Kolmogorov–Smirnov test. The characteristics of the participants were compared using an independent Mann–Whitney U test for continuous data and a chi-square test for categorical data. The sleep duration in different stages of life was compared by the Wilcoxon signed-rank test. Curve estimation was used to estimate the relationship between sleep duration and MoCA scores. Specifically, we compared R 2 of a variety of types of nonlinear regression and found the relationship between sleep duration and MoCA scores showed an inverted U curve. According to the extreme points we got from the curve estimation, we set the cutoff values. When analyzing the sleep duration in one stage, participants were divided separately into two groups by the corresponding cutoff values. In each group, we used logistic regression analysis to examine the association between sleep duration in this stage adjusting demographic characteristics. If there is an association between sleep duration in one stage and aMCI, then we take other covariates that have been reported as influential factors of aMCI as independent variables to adjust the results. We did not impute missing values. Significant values were specified at P < 0.05.

Results

Basic characteristics analysis

A total of 2,977 participants, ranging from 60 to 96 years old, were included in this study. Of these participants, 16.96% were diagnosed with aMCI. Table 1 shows the basic characteristics of all participants. The distribution of age, gender, educational years, smoking history, tea consumption, physical activity, BMI, and sleep duration in late life were all different in late life between the aMCI group and the HC group (Table 1, P < 0.05). Compared to those in the HC group, the participants in the aMCI group were older and had fewer educational years (Table 1, both P < 0.001). The proportion of male participants was lower in the aMCI group (Table 1, P < 0.001). The sleep duration in late life in the aMCI group is less than HC group (Table 1, P = 0.032). In addition, the participants in the aMCI group tended to smoke less (Table 1, P = 0.005), drink tea more (Table 1, P < 0.001), exercise less (Table 1, P < 0.001), and have lower BMI (Table 1, P = 0.004).

Table 1. The basic characteristics of all participants

MMSE, Mini-Mental State Examination; MoCA, Montreal Cognitive Assessment; BMI, body mass index.

aMann–Whitney U test. b χ 2 test.

* P < 0.05, ** P < 0.01.

In the aMCI group, the mean nighttime sleep duration in youth, midlife, and late life were 7.45 ± 1.22, 7.03 ± 1.18, and 6.46 ± 1.54 hours, respectively. While in the HC groups, they were 7.54 ± 1.17, 7.12 ± 1.17, and 6.63 ± 1.36 hours. In both the aMCI and HC groups, the mean nighttime sleep duration showed decreasing tendency with increasing age (Figure 1). The differences in sleep duration between stages of life were significant.

Figure 1. The mean sleep duration presented significant decline with increasing age in HC group and aMCI group, respectively. ** P < 0.01.

Associations between sleep duration in different stages of life and MoCA scores

A nonlinear trend was revealed for the relationship between sleep duration and cognitive function in recent studies (Xu et al., Reference Xu2020b). The curve estimation indicated that the highest MoCA scores were associated with a sleep duration of 9.69 hours in youth. In midlife, the highest point for MoCA scores was associated with 8.71 hours; in late life, the highest point for MoCA scores was associated with 6.87 hours (Table 2).

Table 2. An inverted U relationship between sleep duration in different stages and MoCA scores

** P < 0.01.

According to the extreme points, we took 10 hours in youth, 9 hours in midlife, and 7 hours in late life as cutoff values.

Association between sleep duration in different stages of life and aMCI

Based on these cutoff values in the different age periods, all participants were divided into two groups. Logistic regression was used to assess the relationship between sleep duration and aMCI. In the analysis, there are no results proving that sleep duration in youth (P = 0.719, sleep duration < 10 hours; P = 0.999, sleep duration ≥ 10 hours) or midlife (P = 0.898, sleep duration < 9 hours; P = 0.504, sleep duration ≥ 9 hours) had a significant association with aMCI (Table 3). We found that sleep duration in late life was associated with aMCI (P = 0.012, odds ratio (OR) = 0.81, 95% confidence interval (CI) = 0.69–0.95, Table 3) in the group sleeping less than 7 hours. Conversely, there was no significant association between sleep duration in late life and aMCI when sleeping equal to or more than 7 hours (Table 3).

Table 3. Association between sleep duration in different stages of life and aMCI

Logistic regression adjusted for age, gender, and years of education.

Sleep duration cutoff values were rounding the extreme point in Table 2.

* P < 0.05.

Associations between other factors in late life and aMCI

After taking all variables as independent values into logistic regression, we found each hour more of sleep duration was associated with approximately 0.80 of the original risk of aMCI (P = 0.011, OR = 0.80, 95% CI = 0.68–0.95, Table 4) when sleeping less than 7 hours in late life, as shown in Table 4. Age was a risk factor (sleep duration < 7 hours, P < 0.001, OR = 1.04, 95% CI = 1.02–1.06; P < 0.001, OR = 1.05, 95% CI = 1.03–1.07), while education was an important protective factor (sleep duration < 7 hours, P < 0.001, OR = 0.92, 95% CI = 0.89–0.95; P < 0.001, OR = 0.89, 95% CI = 0.86–0.92) against aMCI. Drinking tea was also a significant protective factor (sleep duration < 7 hours, P = 0.031, OR = 0.70, 95% CI = 0.50–0.97; P < 0.001, OR = 0.46, 95% CI = 0.33–0.65) against aMCI. Additionally, physical activity (sleep duration < 7 hours, P = 0.003, OR = 0.62, 95% CI = 0.45–0.85) played a protective role against aMCI.

Table 4. Logistic regression in each group of sleep duration in late life

BMI, body mass index.

* P < 0.05, ** P < 0.01.

In addition, we took sleep duration as a three-category variable to supplement the relationship between short sleep and aMCI. Considering the sample size in each group, the subjects that slept less than 7 hours were classified into three categories: group 1 (6 hours ≤ sleep duration < 7 hours), group 2 (5 hours ≤ sleep duration < 6 hours), group 3 (sleep duration < 5 hours). First group was taken as the reference group. We received consistent results (online Supplementary Table S1) when taking sleep duration as either a categorical variable or a continuous variable, which both demonstrated that short sleep duration was a risk factor for aMCI when sleeping less than 7 hours (see online Supplementary Table S1 published as supplementary material online attached to the electronic version of this paper).

Discussion

This study presents the associations between aMCI and nighttime sleep duration at different stages of life and revealed other relevant factors for aMCI.

We found that the mean nighttime sleep duration showed a decreasing tendency with increasing age in both the aMCI group and HC group. The National Sleep Foundation (Foundation, Reference Foundation2018) recommends people aged 26–64 years to sleep for 7–9 hours and people aged ≥65 years to sleep for 7–8 hours, which is consistent with our findings. As people age, sleep quality and architecture often change and sleep’s homeostatic and sleep–wake cycle controls vary as well. Changes such as reductions in slow-wave sleep’s (SWS) percent and spectral power in the sleep electroencephalogram, number and amplitude of sleep spindles, rapid eye movement (REM) density, and the amplitude of circadian rhythms (Pace-Schott and Spencer, Reference Pace-Schott, Spencer, Meerlo, Benca and Abel2015) mainly reflect as a sleep of low quality, a decrease in sleep duration, an increase in sleep fragmentation, and a difficulty falling asleep. Besides, some sleep changes are associated with major medical issues, such as cardiovascular diseases or endocrine and metabolic diseases, neuropsychiatric disorders, and sleep disorders, the occurrence of which dramatically increases in middle to late life (Bliwise, Reference Bliwise1993). In the patients with MCI, sleep quality, SWS, spindles, and percent REM are further diminished, compared to normal aging (Pace-Schott and Spencer, Reference Pace-Schott, Spencer, Meerlo, Benca and Abel2015).

In our study, there were no results proving that sleep duration in youth or in midlife had a significant association with aMCI. Some studies reported that sleep duration in early life was associated with cardiovascular disease (Kwok et al., Reference Kwok2018), hyperglycemia (Kim et al., Reference Kim2018), abdominal obesity, and dyslipidemia (Mesas et al., Reference Mesas2014), all of which were reported relevant to aMCI. A larger number of samples with more confounding factors collected in early life are needed to further analyze the association between sleep duration in early life and aMCI. Besides, more subjects sleeping extremely long in early life should be recruited in the future study.

Sleep duration in late life did show an association with aMCI in our study. Short sleep had a relatively higher risk of aMCI. These findings were consistent with previous studies (Rauchs et al., Reference Rauchs2013; Tworoger et al., Reference Tworoger, Lee, Schernhammer and Grodstein2006). Sleep serves host-defense mechanisms, conserves caloric expenditures, and replenishes brain energy stores. When sleeping, there is an increase in convective exchange of interstitial fluid with cerebrospinal fluid, which may also serve to remove neurotoxic products that accumulate during wakefulness (Kang et al., Reference Kang2009). And memory consolidation is dependent on slow-wave and theta activity during sleep (Westerberg et al., Reference Westerberg2012). Spira et al. (Reference Spira2013) found that β-amyloid deposition increased when sleep was less than 7 hours; β-amyloid deposition in brain regions related to AD dramatically increased. Sanchez-Espinosa et al. (Reference Sanchez-Espinosa, Atienza and Cantero2014) found that sleep deficits in those with MCI were related to increased levels of plasma amyloid-β and cortical thinning. Some studies have shown that short sleep periods may cause the loss of white matter and brain atrophy (Adam, Reference Adam, McConnell, Boer, Romijn, Van De Poll and Corner1980; Yaffe et al., Reference Yaffe2016). Alperin et al. (Reference Alperin2019) reported that lower sleep duration was correlated with cortical volume and thickness reductions of a number of regions implicated in aMCI and AD. Some studies show that short sleep duration increased systemic inflammation (Irwin and Vitiello, Reference Irwin and Vitiello2019) and disrupted cortisol circadian rhythms (Abell et al., Reference Abell, Shipley, Ferrie, Kivimäki and Kumari2016), which were implicated in the development and progression of AD. Chronic short sleep (Kincheski et al., Reference Kincheski2017) affected glial function and expression of glutamatergic pre-synaptic and post-synaptic markers as reported. These studies had all suggested that short sleep duration is related to pathological and physiological changes associated with AD. Additionally, short sleep duration is related to the prevalence of aMCI. However, in this study, when sleep duration in late life was more than 7 hours, increases in sleep did not significantly affect the risk of aMCI. Our results may have significant public health implications. Early interventions for sleep problems, modulation of sleep duration, and maintain sleep healthy among elderly may help prevent aMCI. It may have a considerable effect on the independence and quality of life of elderly and their families. In the future study, we can explore whether nighttime sleep duration in late life can be modulated to delay the progression of cognitive decline (Wams et al., Reference Wams, Wilcock, Foster and Wulff2017).

Our study also suggested that age was a risk factor for aMCI, while education and physical activity were protective. Currently, there is a consensus that age and lower education (Caamaño-Isorna et al., Reference Caamaño-Isorna, Corral, Montes-Martínez and Takkouche2006; Crous-Bou et al., Reference Crous-Bou, Minguillón, Gramunt and Molinuevo2017) are risk factors for AD or aMCI. Physical activity as a protective factor for aMCI may work through multiple mechanisms, including activation of brain plasticity, promotion of brain vascularization, stimulation of neurogenesis, reduction in inflammation levels or perhaps, decreased rates of amyloid plaque formation (Crous-Bou et al., Reference Crous-Bou, Minguillón, Gramunt and Molinuevo2017). Many studies have shown that physical activity can reduce cognitive function decline, prevent MCI or AD, and even delay disease progression (Brown et al., Reference Brown, Peiffer and Martins2013; Intlekofer and Cotman, Reference Intlekofer and Cotman2013; Rolland et al., Reference Rolland, Abellan van Kan and Vellas2008). Further study on the proper intensity, mode, and duration of exercise was necessary. Our study was in line with previous studies (Pervin et al., Reference Pervin, Unno, Ohishi, Tanabe, Miyoshi and Nakamura2018; Zhang et al., Reference Zhang2020) and showed beneficial effect of tea on aMCI. Tea contains some effective chemical ingredients that may affect brain function, including tea polyphenols, caffeine, green tea catechins, and so on. They may work through the antioxidant activity, a reduction of brain inflammation and inhibition of amyloid-β aggregation (Kakutani et al., Reference Kakutani, Watanabe and Murayama2019). Green tea, as reported (Lin et al., Reference Lin, Tsai, Tsay and Lin2003), contained more tea polyphenols and caffeine than oolong or black tea. Investigations on the complexity of tea, types of tea, the ratio and temperature of water, or other chemical composition are worthy of further study. Gender, smoking history, alcohol consumption, BMI, hypertension, heart disease, and diabetes are associated with aMCI in the previous study. However, there were no results showing the association between them with aMCI in the sleep duration groups. The severity and medication of disease, the frequency of drinking alcohol, or smoking may affect the results, which calls for further study. After adjusting many influential factors, sleep duration in late life still played a significant role in the prevalence of aMCI.

Besides, there are several influential factors which were not involved in this study. AD is proved to be related to gene. Genes confirmed correlative to AD included APOE (Jablonski et al., Reference Jablonski2021), PSEN1 (Choi et al., Reference Choi2014), PSEN2, APP (Chen et al., Reference Chen2021). More and more studies provided the candidate genes waiting for further verification. Dyslipidemia is another related factor. Over the years, the relationship between cognitive decline and blood lipids is controversial. Different studies (Presečki et al., Reference Presečki2011; Warren et al., Reference Warren, Hynan and Weiner2012; Williams et al., Reference Williams2013) had various conclusions. Medication also influences the prevalence of MCI and AD. Some studies supported the use of non-steroidal anti-inflammatory drugs, antihypertensive medications, and the medicine for diabetes (Tolppanen et al., Reference Tolppanen2013) for the prevention of AD, but a consensus was not reached yet.

In summary, too short sleep duration in late life may increase the risk of aMCI. Among the elderly sleeping less than 7 hours, sleeping more can help reduce the risk of aMCI. Age and lower education are risk factors for aMCI. Improving sleep quality, modulating sleep duration, and developing a habit of physical exercise or drinking tea may reduce the likelihood of aMCI. The present study has several strengths, including a large community-dwelling sample in typical cities of China and sleep duration in different stages of life. Our results may have significant public health implications to alleviate the psychological and financial burden on individuals and society caused by aMCI or AD. Nevertheless, there are several limitations in our study. Firstly, this study was a cross-sectional study and cannot provide causal relationships between sleep duration and aMCI. Additional longitudinal studies are needed to validate the findings. Secondly, as most previous studies, this study depended on self-reported sleep duration. Although self-reported sleep duration was verified by their families, self-reported sleep duration across different stages of life may not be very accurate considering the variability in sleep duration in the long term. Objective sleep assessment tools, such as polysomnography, can be incorporated into subsequent research. Thirdly, other potential factors, such as coffee intake, gene impact, medication, and blood lipid levels, should also be considered. The model was built around the sleep duration. When talking about the effect of covariates, the results were not accurate enough due to the lack of the influential factors for covariates. Fourthly, the sample size of the subjects with very long-time sleep is small so that the analysis of sleep duration in youth or in midlife is simple. Lastly, our results are based on a Chinese population and may not applicable to other races.

Conclusion

Among the elderly sleeping less than 7 hours, there is a decreased risk of aMCI for every additional hour of sleep.

Conflict of interest

None.

Description of authors’ roles

Shifu Xiao, Tao Wang, and Hua Xu supervised the analysis and contributed to the design of the project. Mengya Yuan and Bo Hong contributed to the design of the project and drafting the manuscript. Mengya Yuan, Bo Hong, Wei Zhang, An Liu, Jinghua Wang, Yuanyuan Liu, and Feng Yan carried out the data collection. All authors critically revised the report, commented on drafts of the manuscript, and approved the final report.

Acknowledgements

This work was supported by grants from National Natural Science Foundation of China (81571298), Shanghai Health System Excellent Talent Training Program (2017BR054), Shanghai Pujiang Program (17PJD038), Clinical Research Center, Shanghai Mental Health Center (CRC2019ZD03, CRC2017ZD02).

Supplementary material

To view supplementary material for this article, please visit https://doi.org/10.1017/S1041610221000466

Footnotes

Contributed equally.

References

Abell, J. G., Shipley, M. J., Ferrie, J. E., Kivimäki, M. and Kumari, M. (2016). Recurrent short sleep, chronic insomnia symptoms and salivary cortisol: a 10-year follow-up in the Whitehall II study. Psychoneuroendocrinology, 68, 91–99. doi:https://doi.org/10.1016/j.psyneuen.2016.02.021. CrossRefGoogle Scholar
Adam, K. (1980). Sleep as a Restorative Process and a Theory to Explain Why. In: McConnell, P. S., Boer, G. J., Romijn, H. J., Van De Poll, N. E. and Corner, M. A. (Eds.), Progress in Brain Research (pp 289305). Amsterdam, The Netherlands: Elsevier.Google Scholar
Alperin, N., et al. (2019). Effect of sleep quality on amnestic mild cognitive impairment vulnerable brain regions in cognitively normal elderly individuals. Sleep, 42. doi: 10.1093/sleep/zsy254.CrossRefGoogle Scholar
Anderson, R. M., Hadjichrysanthou, C., Evans, S. and Wong, M. M. (2017). Why do so many clinical trials of therapies for Alzheimer’s disease fail? Lancet, 390, 23272329. doi: 10.1016/s0140-6736(17)32399-1.CrossRefGoogle ScholarPubMed
Benito-León, J., Louis, E. D. and Bermejo-Pareja, F. (2013). Cognitive decline in short and long sleepers: a prospective population-based study (NEDICES). Journal of Psychiatric Research, 47, 19982003. doi: 10.1016/j.jpsychires.2013.09.007.CrossRefGoogle Scholar
Bliwise, D. L. (1993). Sleep in normal aging and dementia. Sleep, 16, 4081. doi: 10.1093/sleep/16.1.40.CrossRefGoogle ScholarPubMed
Brown, B. M., Peiffer, J. J. and Martins, R. N. (2013). Multiple effects of physical activity on molecular and cognitive signs of brain aging: can exercise slow neurodegeneration and delay Alzheimer’s disease? Molecular Psychiatry, 18, 864874. doi: 10.1038/mp.2012.162.CrossRefGoogle ScholarPubMed
Caamaño-Isorna, F., Corral, M., Montes-Martínez, A. and Takkouche, B. (2006). Education and dementia: a meta-analytic study. Neuroepidemiology, 26, 226232. doi: 10.1159/000093378.CrossRefGoogle ScholarPubMed
Campbell, N. L., Unverzagt, F., Lamantia, M. A., Khan, B. A. and Boustani, M. A. (2013). Risk factors for the progression of mild cognitive impairment to dementia. Clinics in Geriatric Medicine, 29, 873.CrossRefGoogle Scholar
Chen, J. C. et al. (2016). Sleep duration, cognitive decline, and dementia risk in older women. Alzheimers & Dementia, 12, 2133. doi: 10.1016/j.jalz.2015.03.004.CrossRefGoogle ScholarPubMed
Chen, Y. et al. (2021). Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice. Alzheimer’s Research & Therapy, 13, 40. doi: 10.1186/s13195-020-00761-9.CrossRefGoogle ScholarPubMed
Choi, S. H. et al. (2014). A three-dimensional human neural cell culture model of Alzheimer’s disease. Nature, 515, 274278. doi: 10.1038/nature13800.CrossRefGoogle ScholarPubMed
Chung, J.-Y. et al. (2019). Reversion from mild cognitive impairment to normal cognition: false-positive error or true restoration thanks to cognitive control ability? Neuropsychiatric Disease and Treatment, 15, 30213032. doi: 10.2147/NDT.S223958.CrossRefGoogle ScholarPubMed
Crous-Bou, M., Minguillón, C., Gramunt, N. and Molinuevo, J. L. (2017). Alzheimer’s disease prevention: from risk factors to early intervention. Alzheimer’s Research & Therapy, 9, 71–71. doi: 10.1186/s13195-017-0297-z.CrossRefGoogle ScholarPubMed
Ding, G., Li, J. and Lian, Z. (2020). Both short and long sleep durations are associated with cognitive impairment among community-dwelling Chinese older adults. Medicine, 99, e19667.CrossRefGoogle Scholar
Foundation, N. S. (2018). National Sleep Foundation Recommends New Sleep Times. Available at: http://sleepfoundation.org/press-release/national-sleep-foundation-recommends-new-sleep-times/page/0/1 Google Scholar
Gil, L., Vega, J. G., Ruiz de Sanchez, C. and Burgos, F. P. (2013). Validation of the Montreal Cognitive Assessment – Spanish Version test (MoCA-S) as a screening tool for mild cognitive impairment and mild dementia in Bogotá, Colombia. Alzheimer’s & Dementia, 9, P452P453. doi:https://doi.org/10.1016/j.jalz.2013.05.904.CrossRefGoogle Scholar
Guarnieri, B. et al. (2012). Prevalence of sleep disturbances in mild cognitive impairment and dementing disorders: a multicenter Italian clinical cross-sectional study on 431 patients. Dementia and Geriatric Cognitive Disorders, 33, 5058. doi: 10.1159/000335363.CrossRefGoogle ScholarPubMed
Guarnieri, B. and Sorbi, S. (2015). Sleep and cognitive decline: a strong bidirectional relationship. It is time for specific recommendations on routine assessment and the management of sleep disorders in patients with mild cognitive impairment and dementia. European Neurology, 74, 4348. doi: 10.1159/000434629.CrossRefGoogle Scholar
Intlekofer, K. A. and Cotman, C. W. (2013). Exercise counteracts declining hippocampal function in aging and Alzheimer’s disease. Neurobiology of Disease, 57, 4755. doi: 10.1016/j.nbd.2012.06.011.CrossRefGoogle ScholarPubMed
Irwin, M. R. and Vitiello, M. V. (2019). Implications of sleep disturbance and inflammation for Alzheimer’s disease dementia. The Lancet Neurology, 18, 296306. doi: 10.1016/S1474-4422(18)30450-2.CrossRefGoogle ScholarPubMed
Jablonski, A. M. et al. (2021). Astrocytic expression of the Alzheimer’s disease risk allele, ApoEϵ4, potentiates neuronal tau pathology in multiple preclinical models. Scientific Reports, 11, 3438. doi: 10.1038/s41598-021-82901-1.CrossRefGoogle ScholarPubMed
Kakutani, S., Watanabe, H. and Murayama, N. (2019). Green tea intake and risks for dementia, Alzheimer’s disease, mild cognitive impairment, and cognitive impairment: a systematic review. Nutrients, 11, 1165. doi: 10.3390/nu11051165.CrossRefGoogle ScholarPubMed
Kang, J.-E. et al. (2009). Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science (New York, N.Y.), 326, 10051007. doi: 10.1126/science.1180962.CrossRefGoogle ScholarPubMed
Kasper, S. et al. (2020). Management of mild cognitive impairment (MCI): the need for national and international guidelines. The World Journal of Biological Psychiatry, 21, 579594. doi: 10.1080/15622975.2019.1696473.CrossRefGoogle ScholarPubMed
Kim, C. E. et al. (2018). Association between sleep duration and metabolic syndrome: a cross-sectional study. BMC Public Health, 18, 720. doi: 10.1186/s12889-018-5557-8.CrossRefGoogle ScholarPubMed
Kincheski, G. C. et al. (2017). Chronic sleep restriction promotes brain inflammation and synapse loss, and potentiates memory impairment induced by amyloid-β oligomers in mice. Brain, Behavior, and Immunity, 64, 140151. doi:https://doi.org/10.1016/j.bbi.2017.04.007.CrossRefGoogle ScholarPubMed
Kwok, C. S. et al. (2018). Self-reported sleep duration and quality and cardiovascular disease and mortality: a dose-response meta-analysis. Journal of the American Heart Association, 7, e008552e008552. doi: 10.1161/JAHA.118.008552.CrossRefGoogle ScholarPubMed
Lin, X. et al. (2016). Screening for depression and anxiety among older Chinese immigrants living in Western countries: the use of the Geriatric Depression Scale (GDS) and the Geriatric Anxiety Inventory (GAI). Asia-Pacific Psychiatry, 8.CrossRefGoogle Scholar
Lin, Y.-S., Tsai, Y.-J., Tsay, J.-S. and Lin, J.-K. (2003). Factors affecting the levels of Tea Polyphenols and Caffeine in Tea Leaves. Journal of Agricultural and Food Chemistry, 51, 18641873. doi: 10.1021/jf021066b.CrossRefGoogle ScholarPubMed
Liu, S. et al. (2020). Sleep spindles, K-complexes, limb movements and sleep stage proportions may be biomarkers for amnestic mild cognitive impairment and Alzheimer’s disease. Sleep and Breathing, 24, 637651. doi: 10.1007/s11325-019-01970-9.CrossRefGoogle ScholarPubMed
Mesas, A. E. et al. (2014). Sleep quality and the metabolic syndrome: the role of sleep duration and lifestyle. Diabetes/Metabolism Research and Reviews, 30, 222231. doi:https://doi.org/10.1002/dmrr.2480.CrossRefGoogle ScholarPubMed
Moroney, J. T., Bagiella, E., Desmond, D. W., Hachinski, V. C. and Tatemichi, T. K. (1997). Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias. Neurology, 49, 1096.CrossRefGoogle ScholarPubMed
Morris, J. C. et al. (2001). Mild cognitive impairment represents early-stage Alzheimer disease. Archives of Neurology, 58, 397405. doi: 10.1001/archneur.58.3.397.CrossRefGoogle ScholarPubMed
O’Bryant, S. E. et al. (2008). Detecting dementia with the mini-mental state examination in highly educated individuals. Archives of Neurology, 65, 963967. doi: 10.1001/archneur.65.7.963.CrossRefGoogle ScholarPubMed
Ohayon, M. M. and Vecchierini, M. F. (2002). Daytime sleepiness and cognitive impairment in the elderly population. Archives of Internal Medicine, 162, 201208. doi: 10.1001/archinte.162.2.201.CrossRefGoogle ScholarPubMed
Pace-Schott, E. F. and Spencer, R. M. C. (2015). Sleep-Dependent Memory Consolidation in Healthy Aging and Mild Cognitive Impairment. In: Meerlo, P., Benca, R. M. and Abel, T. (Eds.), Sleep, Neuronal Plasticity and Brain Function (pp. 307330). Berlin, Heidelberg: Springer Berlin Heidelberg.Google Scholar
Pervin, M., Unno, K., Ohishi, T., Tanabe, H., Miyoshi, N. and Nakamura, Y. (2018). Beneficial effects of green tea catechins on neurodegenerative diseases. Molecules (Basel, Switzerland), 23, 1297. doi: 10.3390/molecules23061297.CrossRefGoogle ScholarPubMed
Portet, F. et al. (2006). Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer’s Disease. Journal of Neurology, Neurosurgery, and Psychiatry, 77, 714718. doi: 10.1136/jnnp.2005.085332.CrossRefGoogle Scholar
Presečki, P. et al. (2011). Serum lipid levels in patients with Alzheimer’s disease. Collegium Antropologicum, 35, 115120.Google ScholarPubMed
Rauchs, G. et al. (2013). Retrieval of recent autobiographical memories is associated with slow-wave sleep in early AD. Frontiers in Behavioral Neuroscience, 7, 114–114. doi: 10.3389/fnbeh.2013.00114.CrossRefGoogle ScholarPubMed
Rolland, Y., Abellan van Kan, G. and Vellas, B. (2008). Physical activity and Alzheimer’s disease: from prevention to therapeutic perspectives. Journal of the American Medical Directors Association, 9, 390405. doi:https://doi.org/10.1016/j.jamda.2008.02.007.CrossRefGoogle ScholarPubMed
Sanchez-Espinosa, M. P., Atienza, M. and Cantero, J. L. (2014). Sleep deficits in mild cognitive impairment are related to increased levels of plasma amyloid-β and cortical thinning. Neuroimage, 98, 395404. doi: 10.1016/j.neuroimage.2014.05.027.CrossRefGoogle ScholarPubMed
Sanford, A. M. (2017). Mild cognitive impairment. Clinics in Geriatric Medicine, 33, 325337. doi: 10.1016/j.cger.2017.02.005.CrossRefGoogle ScholarPubMed
Schmutte, T., Harris, S., Levin, R., Zweig, R., Katz, M. and Lipton, R. (2007). The relation between cognitive functioning and self-reported sleep complaints in nondemented older adults: results from the Bronx Aging Study. Behavioral Sleep Medicine, 5, 3956. doi: 10.1080/15402000709336725.CrossRefGoogle ScholarPubMed
Shi, L. et al. (2018). Sleep disturbances increase the risk of dementia: a systematic review and meta-analysis. Sleep Medicine Reviews, 40, 416. doi:https://doi.org/10.1016/j.smrv.2017.06.010.CrossRefGoogle ScholarPubMed
Spira, A. P. et al. (2013). Self-reported sleep and β-amyloid deposition in community-dwelling older adults. JAMA Neurology, 70, 15371543. doi: 10.1001/jamaneurol.2013.4258.Google ScholarPubMed
Tolppanen, A.-M. et al. (2013). History of medically treated diabetes and risk of Alzheimer Disease in a Nationwide Case-Control Study. Diabetes Care,  7, 20152019. doi: 10.2337/dc12-1287.CrossRefGoogle Scholar
Tworoger, S. S., Lee, S., Schernhammer, E. S. and Grodstein, F. (2006). The association of self-reported sleep duration, difficulty sleeping, and snoring with cognitive function in older women. Alzheimer Disease & Associated Disorders, 20, 4148. doi: 10.1097/01.wad.0000201850.52707.80.CrossRefGoogle ScholarPubMed
Wams, E. J., Wilcock, G. K., Foster, R. G. and Wulff, K. (2017). Sleep-Wake Patterns and Cognition of Older Adults with Amnestic Mild Cognitive Impairment (aMCI): A Comparison with Cognitively Healthy Adults and Moderate Alzheimer’s Disease Patients. Current Alzheimer Research, 14, 10301041. doi: 10.2174/1567205014666170523095634.CrossRefGoogle ScholarPubMed
Warren, M. W., Hynan, L. S. and Weiner, M. F. (2012). Lipids and adipokines as risk factors for Alzheimer’s disease. Journal of Alzheimers Disease, 29, 151. doi: 10.3233/JAD-2012-111385.CrossRefGoogle ScholarPubMed
Westerberg, C. E. et al. (2012). Concurrent impairments in sleep and memory in amnestic mild cognitive impairment. Journal of the International Neuropsychological Society, 18, 490500. doi: 10.1017/s135561771200001x.CrossRefGoogle ScholarPubMed
Williams, V. J. et al. (2013). Interindividual variation in serum cholesterol is associated with regional white matter tissue integrity in older adults. Human Brain Mapping, 34, 18261841. doi: 10.1002/hbm.22030.CrossRefGoogle ScholarPubMed
Xiao, S. et al. (2013). Methodology of China’s national study on the evaluation, early recognition, and treatment of psychological problems in the elderly: the China Longitudinal Aging Study (CLAS). Shanghai Archives of Psychiatry, 25, 9198. doi: 10.3969/j.issn.1002-0829.2013.02.005.Google Scholar
Xu, W., Tan, C.-C., Zou, J.-J., Cao, X.-P. and Tan, L. (2020a). Sleep problems and risk of all-cause cognitive decline or dementia: an updated systematic review and meta-analysis. Journal of Neurology, Neurosurgery and Psychiatry, 91, 236244. doi: 10.1136/jnnp-2019-321896.CrossRefGoogle ScholarPubMed
Xu, W. et al. (2020b). Sleep characteristics and cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in cognitively intact older adults: The CABLE study. Alzheimers and Dementia (N Y), 16, 11461152. doi: https://doi.org/10.1002/alz.12117.CrossRefGoogle ScholarPubMed
Yaffe, K. et al. (2016). Sleep duration and white matter quality in middle-aged adults. Sleep, 39, 17431747. doi: 10.5665/sleep.6104.CrossRefGoogle ScholarPubMed
Zhang, J. et al. (2020). Association between tea consumption and cognitive impairment in middle-aged and older adults. BMC Geriatrics, 20, 447–447. doi: 10.1186/s12877-020-01848-6.CrossRefGoogle ScholarPubMed
Figure 0

Table 1. The basic characteristics of all participants

Figure 1

Figure 1. The mean sleep duration presented significant decline with increasing age in HC group and aMCI group, respectively. ** P < 0.01.

Figure 2

Table 2. An inverted U relationship between sleep duration in different stages and MoCA scores

Figure 3

Table 3. Association between sleep duration in different stages of life and aMCI

Figure 4

Table 4. Logistic regression in each group of sleep duration in late life

Supplementary material: File

Yuan et al. supplementary material

Yuan et al. supplementary material

Download Yuan et al. supplementary material(File)
File 15.8 KB